Background / SignificanceY90 Transarterial radioembolization (TARE)Important role in hepatocellular carcinoma (HCC) treatmentDOSISPHERESARAHHigher doses→improved survivalResin microspheresLess published data than glass microspheres• Tumor-response thresholdShift towards partition dosimetryBody surface area dosimetry historically

- 在肝细胞癌 (HCC) 治疗中的重要作用
       剂量:
- 高剂量→提高生存率

HCC 对钇90树脂微球TARE的反应特征 Characterize HCC response to Y90 resin microsphere TARE

• 鉴定HCC对Y90树脂微球的HCC剂量-反应关系及影响因素 Identify HCC dose-response relationship and influencing factors 

• 建立预测模型 Generate predictive models at 6 months for
• 肿瘤反应Tumor response
  •  6个月无进展生存期 Progression-free-survival